SELLAS Life Sciences (SLS) Total Debt (QoQ) (2013 - 2018)
SELLAS Life Sciences (SLS) Total Debt (QoQ) (2013 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -99.02% |
| Jun 30, 2018 | -19.61% |
| Mar 31, 2018 | -11.94% |
| Dec 31, 2017 | -9.71% |
| Sep 30, 2017 | -6.56% |
| Jun 30, 2017 | 3.40% |
| Mar 31, 2017 | 637.10% |
| Dec 31, 2016 | -92.80% |
| Sep 30, 2016 | 2.44% |
| Jun 30, 2016 | 519.17% |
| Mar 31, 2016 | -21.08% |
| Dec 31, 2015 | -16.74% |
| Sep 30, 2015 | -14.08% |
| Jun 30, 2015 | -12.00% |
| Mar 31, 2015 | -10.40% |
| Dec 31, 2014 | -9.27% |
| Sep 30, 2014 | -8.13% |
| Jun 30, 2014 | 0.94% |
| Mar 31, 2014 | 0.94% |
| Dec 31, 2013 | 0.96% |